Literature DB >> 23955631

Sprouty4 regulates endothelial cell migration via modulating integrin β3 stability through c-Src.

Yan Gong1, Xuehui Yang, Qing He, Lindsey Gower, Igor Prudovsky, Calvin P H Vary, Peter C Brooks, Robert E Friesel.   

Abstract

Angiogenesis is mediated by signaling through receptor tyrosine kinases (RTKs), Src family kinases and adhesion receptors such as integrins, yet the mechanism how these signaling pathways regulate one another remains incompletely understood. The RTK modulator, Sprouty4 (Spry4) inhibits endothelial cell functions and angiogenesis, but the mechanisms remain to be fully elucidated. In this study, we demonstrate that Spry4 regulates angiogenesis in part by regulating endothelial cell migration. Overexpression of Spry4 in human endothelial cells inhibited migration and adhesion on vitronectin (VTN), whereas knockdown of Spry4 enhanced these behaviors. These activities were shown to be c-Src-dependent and Ras-independent. Spry4 disrupted the crosstalk between vascular endothelial growth factor-2 and integrin αVβ3, the receptor for VTN. Spry4 overexpression resulted in decreased integrin β3 protein levels in a post-transcriptional manner in part by modulating its tyrosine phosphorylation by c-Src. Conversely, knockdown of Spry4 resulted in increased integrin β3 protein levels and tyrosine phosphorylation. Moreover, in vivo analysis revealed that Spry4 regulated integrin β3 levels in murine embryos and yolk sacs. Our findings identify an unanticipated role for Spry4 in regulating c-Src activity and integrin β3 protein levels, which contributes to the regulation of migration and adhesion of endothelial cells. Thus, targeting Spry4 may be exploited as a target in anti-angiogenesis therapies.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23955631      PMCID: PMC3790316          DOI: 10.1007/s10456-013-9361-x

Source DB:  PubMed          Journal:  Angiogenesis        ISSN: 0969-6970            Impact factor:   9.596


  49 in total

1.  Ubiquitination of alpha 5 beta 1 integrin controls fibroblast migration through lysosomal degradation of fibronectin-integrin complexes.

Authors:  Viola Hélène Lobert; Andreas Brech; Nina Marie Pedersen; Jørgen Wesche; Angela Oppelt; Lene Malerød; Harald Stenmark
Journal:  Dev Cell       Date:  2010-07-20       Impact factor: 12.270

Review 2.  Sprouty proteins: modified modulators, matchmakers or missing links?

Authors:  G R Guy; R A Jackson; P Yusoff; S Y Chow
Journal:  J Endocrinol       Date:  2009-05-07       Impact factor: 4.286

Review 3.  Integrins: the keys to unlocking angiogenesis.

Authors:  Rita Silva; Gabriela D'Amico; Kairbaan M Hodivala-Dilke; Louise E Reynolds
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-07-24       Impact factor: 8.311

Review 4.  Integrins: masters and slaves of endocytic transport.

Authors:  Patrick T Caswell; Suryakiran Vadrevu; Jim C Norman
Journal:  Nat Rev Mol Cell Biol       Date:  2009-12       Impact factor: 94.444

5.  Sprouty4 deficiency potentiates Ras-independent angiogenic signals and tumor growth.

Authors:  Koji Taniguchi; Takuma Ishizaki; Toranoshin Ayada; Yuki Sugiyama; Yu Wakabayashi; Takashi Sekiya; Ryusuke Nakagawa; Akihiko Yoshimura
Journal:  Cancer Sci       Date:  2009-05-12       Impact factor: 6.716

6.  Overexpression of Spry1 in chondrocytes causes attenuated FGFR ubiquitination and sustained ERK activation resulting in chondrodysplasia.

Authors:  Xuehui Yang; Lauren K Harkins; Olga Zubanova; Anne Harrington; Dmitry Kovalenko; Robert J Nadeau; Pei-Yu Chen; Jessica L Toher; Volkhard Lindner; Lucy Liaw; Robert Friesel
Journal:  Dev Biol       Date:  2008-06-09       Impact factor: 3.582

Review 7.  Sprouty proteins, masterminds of receptor tyrosine kinase signaling.

Authors:  Miguel A Cabrita; Gerhard Christofori
Journal:  Angiogenesis       Date:  2008-01-25       Impact factor: 9.596

Review 8.  Cooperation between integrin alphavbeta3 and VEGFR2 in angiogenesis.

Authors:  Payaningal R Somanath; Nikolay L Malinin; Tatiana V Byzova
Journal:  Angiogenesis       Date:  2009-03-08       Impact factor: 9.596

Review 9.  Angiogenic and antiangiogenic factors in proliferative diabetic retinopathy.

Authors:  Rafael Simó; Esther Carrasco; Marta García-Ramírez; Cristina Hernández
Journal:  Curr Diabetes Rev       Date:  2006-02

10.  Suppression of Sproutys has a therapeutic effect for a mouse model of ischemia by enhancing angiogenesis.

Authors:  Koji Taniguchi; Ken-ichiro Sasaki; Kousuke Watari; Hideo Yasukawa; Tsutomu Imaizumi; Toranoshin Ayada; Fuyuki Okamoto; Takuma Ishizaki; Reiko Kato; Ri-ichiro Kohno; Hiroshi Kimura; Yasufumi Sato; Mayumi Ono; Yoshikazu Yonemitsu; Akihiko Yoshimura
Journal:  PLoS One       Date:  2009-05-08       Impact factor: 3.240

View more
  13 in total

1.  Sprouty2 protein in prediction of post-treatment ascites in epithelial ovarian cancer treated with adjuvant carbotaxol chemotherapy.

Authors:  Samar Masoumi-Moghaddam; Afshin Amini; Ai-Qun Wei; Gregory Robertson; David L Morris
Journal:  Am J Cancer Res       Date:  2015-07-15       Impact factor: 6.166

2.  Endothelial TWIST1 promotes pathological ocular angiogenesis.

Authors:  Jie Li; Chi-Hsiu Liu; Ye Sun; Yan Gong; Zhongjie Fu; Lucy P Evans; Katherine T Tian; Aimee M Juan; Christian G Hurst; Akiko Mammoto; Jing Chen
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-11-20       Impact factor: 4.799

3.  miR-188-3p targets skeletal endothelium coupling of angiogenesis and osteogenesis during ageing.

Authors:  Wen-Zhen He; Mi Yang; Yangzi Jiang; Chen He; Yu-Chen Sun; Ling Liu; Mei Huang; Yu-Rui Jiao; Kai-Xuan Chen; Jing Hou; Min Huang; Yi-Li Xu; Xu Feng; Ya Liu; Qi Guo; Hui Peng; Yan Huang; Tian Su; Ye Xiao; Yusheng Li; Chao Zeng; Guanghua Lei; Xiang-Hang Luo; Chang-Jun Li
Journal:  Cell Death Dis       Date:  2022-05-25       Impact factor: 9.685

4.  FOXO1 represses sprouty 2 and sprouty 4 expression to promote arterial specification and vascular remodeling in the mouse yolk sac.

Authors:  Nanbing Li-Villarreal; Rebecca Lee Yean Wong; Monica D Garcia; Ryan S Udan; Ross A Poché; Tara L Rasmussen; Alexander M Rhyner; Joshua D Wythe; Mary E Dickinson
Journal:  Development       Date:  2022-04-01       Impact factor: 6.862

Review 5.  Integrin function in vascular biology: a view from 2013.

Authors:  Edward F Plow; Julia Meller; Tatiana V Byzova
Journal:  Curr Opin Hematol       Date:  2014-05       Impact factor: 3.284

6.  Identification of an Endogenously Generated Cryptic Collagen Epitope (XL313) That May Selectively Regulate Angiogenesis by an Integrin Yes-associated Protein (YAP) Mechano-transduction Pathway.

Authors:  Jacquelyn J Ames; Liangru Contois; Jennifer M Caron; Eric Tweedie; Xuehui Yang; Robert Friesel; Calvin Vary; Peter C Brooks
Journal:  J Biol Chem       Date:  2015-12-14       Impact factor: 5.157

7.  BMP9 Crosstalk with the Hippo Pathway Regulates Endothelial Cell Matricellular and Chemokine Responses.

Authors:  Kira Young; Eric Tweedie; Barbara Conley; Jacquelyn Ames; MaryLynn FitzSimons; Peter Brooks; Lucy Liaw; Calvin P H Vary
Journal:  PLoS One       Date:  2015-04-24       Impact factor: 3.240

8.  PTP1B inhibitor promotes endothelial cell motility by activating the DOCK180/Rac1 pathway.

Authors:  Yuan Wang; Feng Yan; Qing Ye; Xiao Wu; Fan Jiang
Journal:  Sci Rep       Date:  2016-04-07       Impact factor: 4.379

9.  Fenofibrate Inhibits Cytochrome P450 Epoxygenase 2C Activity to Suppress Pathological Ocular Angiogenesis.

Authors:  Yan Gong; Zhuo Shao; Zhongjie Fu; Matthew L Edin; Ye Sun; Raffael G Liegl; Zhongxiao Wang; Chi-Hsiu Liu; Samuel B Burnim; Steven S Meng; Fred B Lih; John Paul SanGiovanni; Darryl C Zeldin; Ann Hellström; Lois E H Smith
Journal:  EBioMedicine       Date:  2016-09-30       Impact factor: 8.143

10.  Suppression of Spry4 enhances cancer stem cell properties of human MDA-MB-231 breast carcinoma cells.

Authors:  Hongyu Jing; Lucy Liaw; Robert Friesel; Calvin Vary; Shucheng Hua; Xuehui Yang
Journal:  Cancer Cell Int       Date:  2016-03-11       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.